Evaluating treatment options for acute myeloid leukaemia

Bookmark and Share
Published: 26 Jul 2019
Views: 1092
Rating:
Save
Dr Amanda Brahim - Memorial Healthcare System, Hollywood, FL, USA

Dr Amanda Brahim speaks to ecancer at the 2019 ASCO Direct Highlights Symposium in Miami about shifting treatment options for acute myeloid leukaemia (AML).

She explains that the panel session looked at case studies and discussed which treatment option the panel members would use.

Dr Brahim comments that the panel tried to address questions that have arisen from recent breakthroughs in available targetable agents - although they do not yet have all the answers.